XPO5 and cancer: By cancer tissue microarrays (TMAs) and the cancer genome atlas (TCGA) RNA seq-data, it was shown that increased level of XPO5 promotes and sustain tumor including prostate cancer, breast cancer, ovarian cancer, and bladder cancer (75–77).